Profil
Mr. Christopher Benecchi is a Chief Operating Officer at Inventiva SA. Mr. Benecchi was previously employed as a COO, Principal Financial & Accounting Officer by SAGE Therapeutics, Inc., a Vice President & Global Head-Commercial Excellence by Alexion Pharmaceuticals, Inc., a Global Launch Head-Commercial & Medical Affairs by UCB, Inc., and a Chief Executive Officer by Motric Bio, Inc. He received his undergraduate degree from Colby College and an MBA from Duke University.
Postes actifs de Christopher Benecchi
| Sociétés | Poste | Début |
|---|---|---|
| INVENTIVA | Directeur des opérations | 31/08/2026 |
Anciens postes connus de Christopher Benecchi
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur Financier/CFO | 01/08/2025 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2021 |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01/08/2019 |
Formation de Christopher Benecchi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colby College
Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
















